Adult patients with severe and very severe ME/CFS in Austria. A multi-perspective study.
Dauer: 15 Monate, Fördersumme: € 99.752
Deciphering systemic and mucosal antibody repertoires against the microbiota in ME/CFS and PCC
Dauer: 15 Monate, Fördersumme: € 99.426
The role of the skeletal muscle and myocardial metabolism in ME/CFS: in vivo MRS study.
Dauer: 15 Monate, Fördersumme: € 99.982
Exploring the Glycome: Identifying Glycosylation-Related Biomarkers for severity stratification in Chronic Fatigue Syndrome
Dauer: 12 Monate, Fördersumme: € 99.946
Investigating Cerebral Oxygen Metabolism Dysfunction as a pathomechanism of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Dauer: 14 Monate, Fördersumme: € 96.550